Archive for the 'Entheogens/Psychedelics' Category

French bread spiked with LSD in CIA experiment

In 1951, a quiet, picturesque village in southern France was suddenly and mysteriously struck down with mass insanity and hallucinations. At least five people died, dozens were interned in asylums and hundreds afflicted.

For decades it was assumed that the local bread had been unwittingly poisoned with a psychedelic mould. Now, however, an American investigative journalist has uncovered evidence suggesting the CIA peppered local food with the hallucinogenic drug LSD as part of a mind control experiment at the height of the Cold War.

[...]

On August 16, 1951, the inhabitants were suddenly racked with frightful hallucinations of terrifying beasts and fire.

One man tried to drown himself, screaming that his belly was being eaten by snakes. An 11-year-old tried to strangle his grandmother. Another man shouted: “I am a plane”, before jumping out of a second-floor window, breaking his legs. He then got up and carried on for 50 yards. Another saw his heart escaping through his feet and begged a doctor to put it back. Many were taken to the local asylum in strait jackets.

Telegraph.Co.Uk

Trailer for “Dirty Pictures,” a documentary about Sasha Shulgin

Daniel Pinchbeck in Lawrence, KS

Daniel Pinchbeck at Burning Man

Here’s my recording of Daniel Pinchbeck’s recent lecture at the Alton Ballroom in Lawrence, KS. You can either download the mp3 from here or listen below…

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

Happy Bicycle Day

Hofmann_Bike_Ride_1943

LSD inventor Albert Hofmann dies

Albert Hofmann, the Swiss chemist who discovered the hallucinogenic drug LSD, has died of a heart attack at his home in Basel at the age of 102.

Mr Hofmann first produced LSD in 1938 while researching the medicinal uses of a crop fungus.

He accidentally ingested some of the drug and said later: “Everything I saw was distorted as in a warped mirror.”

He argued for decades that LSD could help treat mental illness, but in the 1960s it became a popular street drug.

‘Turn on, tune in, drop out’
BBC news

Texas’ Peyote Hunters Struggle to Find a Vanishing, Holy Crop

Mauro Morales picks his way through mesquite trees and prickly pear cacti. The 65-year-old cautiously steps around a thicket of tasajillo, or rattail cactus, just down the road from his small ranch near Rio Grande City. Tasajillo thorns stick you like a fish hook, he says. Then there’s the cola seca—the rattlesnake—another job hazard.

“We’re far enough from a hospital that you probably wouldn’t make it if you got bit,” he says in a quiet voice, as though a snake might take his words as an invitation to strike.

Morales has been wandering through the chaparral for half an hour, staring at the ground. He combs over small rocks with a stick. Finally, he spots a greenish knob, sprouting out of the ground under the tasajillo thicket.

“There’s some medicine, right there,” he says. It’s a lone peyote button, about an inch in diameter, way too small to harvest. It’ll be another five years before this peyote is mature. As he navigates the hostile flora, he points to three more small peyote plants, all of them too young to cut.

“I used to collect as much in a week as I now do in a month,” he says. “I don’t know what’s going to happen to the medicine.”

Dallas Observer via Dose Nation

Horizon: Britain’s Most Dangerous Drug

Breaking the Drug Taboo: Group of Traumatized Veterans Get Ecstasy Treatment

An experimental study that treats PTSD veterans with the drug MDMA could make life after war a lot more livable.

“We need to be positioning ourselves now to provide the assistance that our veterans need,” said House Committee on Veterans’ Affairs chairman Bob Filner (D-CA) during a hearing, called “Stopping Suicides: Examining the Mental Health Challenges Facing the Department of Veterans Affairs,” held in December 2007. “Not only for those brave men and women who are returning home from Iraq and Afghanistan, but also for our veterans from previous conflicts. We cannot afford to put this issue off.”

Filner’s choice of words is instructive, as are his sentiments: With upwards of 25 million veterans in the United States, not counting those overseas in the morally murky theater of Iraq and Afghanistan who may return home sometime after the 2008 presidential election, that’s a lot of assistance and funding needed to head off what he called a “rate of veteran suicide [that] has reached epidemic proportions,” to the point that it has doubled the suicide rate of civilians. Safeguards already put into place have failed, for a variety of reasons, and given the severity of the mental and physical problems carried by returning soldiers, some daring out-of-the-box thinking is not only desperately needed, but required.

Enter the Multidisciplinary Association for Psychedelic Studies (MAPS), and its currently funded trials using 3,4-methylenedioxy-N-methamphetamine—otherwise known as MDMA, or ecstasy—to treat post-traumatic stress disorder (PTSD). Although the U.S. Army had carried out lethal dose studies of MDMA back in the 1950s, work which was not classified until the close of the 1960s, it was only centered on animals and was mixed in with a variety of other compounds. At the closure of that research, MDMA languished in clinical obscurity until its rise as a club drug in the ‘80s and ‘90s brought it the kind of attention that dooms better drugs to Schedule I classifications—that is, illegality—and lesser drugs to approval by the Food and Drug Administration (FDA). But MAPS founder and president Rick Doblin became aware of MDMA in 1982, and since then has been convinced of its therapeutic uses. Accordingly, his organization has coordinated and/or funded recent studies into MDMA treatment of PTSD and has its eyes set on a higher goal.

“We’re looking to make MDMA into a prescription medication in the United States, United Kingdom and elsewhere,” he explained by phone.

Entheology

Cruising the Amazon

Life is everywhere in the upper Amazon wilderness. Life that creeps, life that crawls, life that slithers, sprouts, burrows, scurries and slinks—and dies. The dank odors of alternating rot and genesis rise from the mulching forest floor. My Deet-fortified insect spray battles swarms of blood-mad mosquitoes to a draw. The air is fat with syrupy humidity, and I am sweating like an icicle in the sun.

Nature is on fast-forward here. Trees—palms, laurels, kapoks, mahoganies, bamboos, acacias, figs, balsas, cedars—jostle each other in the search for a share of the sunlight; they grow to enormous heights and spread their foliage like a green umbrella at the top. Lianas, tropical climbing plants, wind themselves like boa constrictors around the tree trunks and arch themselves in great loops as they, too, struggle upward for a glimpse of light. The trees become parasites, and giant orchids seed themselves in branches 60 feet from the ground. The general effect is of a an impenetrable fecund, living wall.

Amid this vast assortment of life, creatures use stunts and flim-flam to befuddle or repel predators, lure prey, seduce mates and gobble food. Caterpillars masquerade as snakes, plants imitate the smell of rotting meat to attract flies as pollinators, and trees rely on fish to distribute their seeds when the rivers flood.

It’s a jungle out here.

Chicago Tribune

Curing Addiction with Ibogaine

via Cult of the Dead Cow

Psychedelic Healing?

Mind-altering psychedelics are back—but this time they are being explored in labs for their therapeutic applications rather than being used illegally. Studies are looking at these hallucinogens to treat a number of otherwise intractable psychiatric disorders, including chronic depression, post-traumatic stress disorder, and drug or alcohol dependency.

The past 15 years have seen a quiet resurgence of psychedelic drug research as scientists have come to recognize the long-underappreciated potential of these drugs. In the past few years, a growing number of studies using human volunteers have begun to explore the possible therapeutic benefits of drugs such as LSD, psilocybin, DMT, MDMA, ibogaine and ketamine.

Much remains unclear about the precise neural mechanisms governing how these drugs produce their mind-bending results, but they often produce somewhat similar psychoactive effects that make them potential therapeutic tools. Though still in their preliminary stages, studies in humans suggest that the day when people can schedule a psychedelic session with their therapist to overcome a serious psychiatric problem may not be that far off.

Scientific American via Dose Nation

New Maps of Hyperspace by Terence McKenna

terence mckennaIf one leaves aside the last three hundred years of historical experience as it unfolded in Europe and America, and examines the phenomenon of death and the doctrine of the soul in all its ramifications—Neoplatonic, Christian, dynastic-Egyptian, and so on, one finds repeatedly the idea that there is a light body, an entelechy that is somehow mixed up with the body during life and at death is involved in a crisis in which these two portions separate. One part loses its raison d’etre and falls into dissolution; metabolism stops. The other part goes we know not where. Perhaps nowhere if one believes it does not exist; but then one has the problem of trying to explain life. And, though science makes great claims and has done well at explaining simple atomic systems, the idea that science can make any statement about what life is or where it comes from is currently preposterous.

Electric Kool-Aid Talkshow with Tom Snyder

Jerry Garcia and Ken Kesey on the The Tomorrow Show

The Dark Legacy of Carlos Castaneda

For fans of the literary con, it’s been a great few years. Currently, we have Richard Gere starring as Clifford Irving in “The Hoax,” a film about the ‘70s novelist who penned a faux autobiography of Howard Hughes. We’ve had the unmasking of James Frey, JT LeRoy/Laura Albert and Harvard’s Kaavya Viswanathan, who plagiarized large chunks of her debut novel, forcing her publisher, Little, Brown and Co., to recall the book. Much has been written about the slippery boundaries between fiction and nonfiction, the publishing industry’s responsibility for distinguishing between the two, and the potential damage to readers. There’s been, however, hardly a mention of the 20th century’s most successful literary trickster: Carlos Castaneda.

If this name draws a blank for readers under 30, all they have to do is ask their parents. Deemed by Time magazine the “Godfather of the New Age,” Castaneda was the literary embodiment of the Woodstock era. His 12 books, supposedly based on meetings with a mysterious Indian shaman, don Juan, made the author, a graduate student in anthropology, a worldwide celebrity. Admirers included John Lennon, William Burroughs, Federico Fellini and Jim Morrison.

Under don Juan’s tutelage, Castaneda took peyote, talked to coyotes, turned into a crow, and learned how to fly. All this took place in what don Juan called “a separate reality.” Castaneda, who died in 1998, was, from 1971 to 1982, one of the best-selling nonfiction authors in the country. During his lifetime, his books sold at least 10 million copies.

Castaneda was viewed by many as a compelling writer, and his early books received overwhelmingly positive reviews. Time called them “beautifully lucid” and remarked on a “narrative power unmatched in other anthropological studies.” They were widely accepted as factual, and this contributed to their success. Richard Jennings, an attorney who became closely involved with Castaneda in the ‘90s, was studying at Stanford in the early ‘70s when he read the first two don Juan books. “I was a searcher,” he recently told Salon. “I was looking for a real path to other worlds. I wasn’t looking for metaphors.”

salon

Magic Mushroom Produces Short Term Benefits for Sufferers of OCD

“Doc, I am ready to play ball.”

It had been years since Jeremy (not his real name) had touched a basketball.

Living with obsessive-compulsive disorder (OCD), Jeff feared contamination from dirt and germs which prevented any part of his body from touching the ground, save for the soles of his shoes.

But whilst taking part in a small clinical study to investigate the effects of psilocybin, the hallucinogenic compound found in ‘magic’ mushrooms, on people with OCD, Jeremy’s bare feet lay on the floor and he expressed a willingness to engage in an activity, playing with a ball, that just hours before he would have been considered abhorrent.

Although Jeremy’s symptoms gradually returned, other patients also experienced transient relief from their OCD symptoms and one entered an extended period of remission lasting more than six months.

Lead researcher Dr Francis Moreno, associate professor of psychiatry at the University of Arizona, Tucson, said: “I really think that participating in the study influenced the patient’s remission.”

It was the first to investigate the therapeutic benefits of psilocybin to be published for more than 30 years.

bbc
minkhacks follows up